FDA NDC Directory · JSON-LD · Markdown

PIQRAY

NDC 0078-0701 · HUMAN PRESCRIPTION DRUG · TABLET

Generic namealpelisib
Labeler / ManufacturerNovartis Pharmaceuticals Corporation
Marketing categoryNew Drug Application (innovator) · App NDA212526
Dosage form / routeTABLET · ORAL
Active ingredientsALPELISIB (200 mg/1)
Marketing started20190524
Package count1

External sources

Source: openFDA. Public-domain (CC0).